$BWIN
Baldwin Insurance Group, Inc. Stock $bwin

$bwin Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000178175523000014 Filed on May 09, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$330.4M	$242.8M
YoY Change	36.07%	58.93%
Cost Of Revenue	$231.0M	$153.8M
YoY Change	50.21%	71.98%
Gross Profit	$99.49M	$89.10M
YoY Change	11.67%	40.31%
Gross Profit Margin	30.11%	36.69%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.348M	$988.0K
YoY Change	36.44%	66.33%
% of Gross Profit	1.35%	1.11%
Operating Expenses	$95.87M	$49.36M
YoY Change	94.23%	81.47%
Operating Profit	$3.619M	$39.74M
YoY Change	-90.89%	7.55%
Interest Expense	-$27.88M	-$10.35M
YoY Change	169.41%	84.82%
% of Operating Profit	-770.49%	-26.05%
Other Income/Expense, Net	-$29.40M	$5.101M
YoY Change	-676.26%	-190.4%
Pretax Income	-$25.78M	$44.84M
YoY Change	-157.49%	43.22%
Income Tax	$78.00K	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$14.13M	$22.87M
YoY Change	-161.8%	49.41%
Net Earnings / Revenue	-4.28%	9.42%
Basic Earnings Per Share	-$0.24	$0.41
Diluted Earnings Per Share	-$0.24	$0.39
COMMON SHARES
Basic Shares Outstanding	58.71M shares	55.72M shares
Diluted Shares Outstanding	58.71M shares	58.72M shares

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$81.30M	$156.8M
YoY Change	-48.15%	73.27%
Cash & Equivalents	$81.30M	$156.8M
Short-Term Investments
Other Short-Term Assets	$118.7M	$101.3M
YoY Change	17.17%	176.84%
Inventory
Prepaid Expenses
Receivables	$580.3M	$375.3M
Other Receivables	$114.0K	$1.757M
Total Short-Term Assets	$780.5M	$635.2M
YoY Change	22.87%	90.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.47M	$18.28M
YoY Change	39.33%	57.9%
Goodwill	$1.422B	$1.232B
YoY Change	15.39%	84.18%
Intangibles	$1.081B	$927.6M
YoY Change	16.54%	69.35%
Long-Term Investments
YoY Change
Other Assets	$43.88M	$45.54M
YoY Change	-3.66%	207.83%
Total Long-Term Assets	$2.668B	$2.307B
YoY Change	15.65%	84.31%
TOTAL ASSETS
Total Short-Term Assets	$780.5M	$635.2M
Total Long-Term Assets	$2.668B	$2.307B
Total Assets	$3.448B	$2.942B
YoY Change	17.21%	85.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$544.1M	$361.6M
YoY Change	50.48%	972.91%
Accrued Expenses	$11.03M	$13.31M
YoY Change	-17.14%	-92.47%
Deferred Revenue	$26.03M	$22.06M
YoY Change	18.02%	165.52%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.509M	$8.521M
YoY Change	-0.14%	113.03%
Total Short-Term Liabilities	$772.8M	$531.3M
YoY Change	45.46%	112.23%
LONG-TERM LIABILITIES
Long-Term Debt	$1.294B	$888.2M
YoY Change	45.67%	133.24%
Other Long-Term Liabilities	$250.0K	$3.959M
YoY Change	-93.69%	64.41%
Total Long-Term Liabilities	$250.0K	$3.959M
YoY Change	-93.69%	64.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$772.8M	$531.3M
Total Long-Term Liabilities	$250.0K	$3.959M
Total Liabilities	$2.321B	$1.703B
YoY Change	36.3%	109.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$110.9M	-$32.12M
YoY Change	245.22%	230.04%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$606.4M	$639.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.448B	$2.942B
YoY Change	17.21%	86.55%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$14.13M	$22.87M
YoY Change	-161.8%	49.41%
Depreciation, Depletion And Amortization	$1.348M	$988.0K
YoY Change	36.44%	66.33%
Cash From Operating Activities	-$14.03M	-$3.433M
YoY Change	308.71%	-204.44%
INVESTING ACTIVITIES
Capital Expenditures	$3.499M	$1.793M
YoY Change	95.15%	79.3%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$100.0K	-$639.0K
YoY Change	-84.35%	-96.32%
Cash From Investing Activities	-$5.099M	-$3.132M
YoY Change	62.8%	-82.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$2.127M	$2.127M
YoY Change	0.0%	112.7%
Cash From Financing Activities	-$24.52M	$22.74M
YoY Change	-207.86%	-616.26%
NET CHANGE
Cash From Operating Activities	-$14.03M	-$3.433M
Cash From Investing Activities	-$5.099M	-$3.132M
Cash From Financing Activities	-$24.52M	$22.74M
Net Change In Cash	-$43.65M	$16.17M
YoY Change	-369.94%	-183.03%
FREE CASH FLOW
Cash From Operating Activities	-$14.03M	-$3.433M
Capital Expenditures	$3.499M	$1.793M
Free Cash Flow	-$17.53M	-$5.226M
YoY Change	235.44%	-328.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001781755
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39095
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BRP GROUP, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	61-1937225
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4211 W. Boy Scout Blvd.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Tampa
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33607
CY2023Q1	dei	City Area Code CityAreaCode	866
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	279-0698
CY2023Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	BRP
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81299000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118090000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	105520000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	112381000	usd
CY2023Q1	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	580343000	usd
CY2022Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	531992000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13199000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9823000	usd
CY2023Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	114000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	113000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	780475000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	772399000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25470000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25405000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95316000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	96465000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43878000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	45935000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1081074000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1099918000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1422060000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1422060000	usd
CY2023Q1	us-gaap	Assets Assets	3448273000	usd
CY2022Q4	us-gaap	Assets Assets	3462182000	usd
CY2023Q1	brp	Premiums Payable To Insurance Companies PremiumsPayableToInsuranceCompanies	481131000	usd
CY2022Q4	brp	Premiums Payable To Insurance Companies PremiumsPayableToInsuranceCompanies	471294000	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	62954000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	53927000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	108641000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	125743000	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1525000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1525000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	118569000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	46717000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	772820000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	699206000	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	485000000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	505000000	usd
CY2023Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	808765000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	809862000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	167588000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	220219000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	86739000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87692000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	250000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	164000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2321162000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2322143000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	538000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	487000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	716645000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	704291000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110896000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96764000	usd
CY2023Q1	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	21000	usd
CY2022Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	42000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	606359000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	608104000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	520214000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	531448000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1126573000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1139552000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3448273000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3462182000	usd
CY2023Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	330446000	usd
CY2022Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	242848000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	230954000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	153750000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	46604000	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	36442000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23163000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17562000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	24758000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5632000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1348000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	988000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	326827000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	203110000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3619000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	39738000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-27884000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10350000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1511000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15451000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29395000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5101000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25776000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44839000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	78000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-25854000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	44839000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11722000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	21970000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-14132000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	22869000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-25854000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	44839000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-11722000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	21970000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14132000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22869000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58711798	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55719803	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58711798	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58715825	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1139552000	usd
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-25905000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12916000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	11000	usd
CY2023Q1	brp	Reduction Of Stockholders Notes Payable To Member Units ReductionOfStockholdersNotesPayableToMemberUnits	21000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1126573000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1187287000	usd
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	44820000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6596000	usd
CY2022Q1	brp	Reduction Of Stockholders Notes Payable To Member Units ReductionOfStockholdersNotesPayableToMemberUnits	44000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1238747000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-25854000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	44839000	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	24511000	usd
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	18550000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	24758000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5632000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	13281000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7564000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1407000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	15810000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	857000	usd
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	11117000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1239000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1286000	usd
CY2023Q1	brp	Fair Value Adjustments Other FairValueAdjustmentsOther	100000	usd
CY2022Q1	brp	Fair Value Adjustments Other FairValueAdjustmentsOther	0	usd
CY2023Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	48351000	usd
CY2022Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	35359000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4859000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8908000	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	1000	usd
CY2022Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	89000	usd
CY2023Q1	brp	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-1149000	usd
CY2022Q1	brp	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	1368000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-163000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	627000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-468000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1984000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	77000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14031000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3433000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3499000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1793000	usd
CY2023Q1	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	1500000	usd
CY2022Q1	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	700000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	100000	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	639000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5099000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3132000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4680000	usd
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	13993000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	40000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	70000000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2127000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2127000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1188000	usd
CY2023Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	2275000	usd
CY2022Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	11000	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2023Q1	brp	Proceeds From Collection Of Stock Subscription Receivable ProceedsFromCollectionOfStockSubscriptionReceivable	21000	usd
CY2022Q1	brp	Proceeds From Collection Of Stock Subscription Receivable ProceedsFromCollectionOfStockSubscriptionReceivable	44000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24522000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22736000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-43652000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16171000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	230471000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227737000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186819000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	243908000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	24898000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	9049000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3071000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5336000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1084000	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	usd
CY2023Q1	brp	Right Of Use Assets Increased Through Lease Modifications And Reassessments RightOfUseAssetsIncreasedThroughLeaseModificationsAndReassessments	61000	usd
CY2022Q1	brp	Right Of Use Assets Increased Through Lease Modifications And Reassessments RightOfUseAssetsIncreasedThroughLeaseModificationsAndReassessments	0	usd
CY2023Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	usd
CY2022Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	3658000	usd
CY2023Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2022Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	92000	usd
CY2023Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-07-01
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates underlying the accompanying consolidated financial statements include the application of guidance for revenue recognition; the valuation of acquired relationships and contingent consideration; impairment of long-lived assets and goodwill; share-based compensation related to performance-based restricted stock unit awards; and the valuation allowance for deferred tax assets.
CY2023Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	330446000	usd
CY2022Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	242848000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2023Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	346824000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	278023000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26033000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30981000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	26200000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	21669000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	11336000	usd
CY2023Q1	brp	Capitalized Contract Cost Capitalized Amount CapitalizedContractCostCapitalizedAmount	3372000	usd
CY2022Q1	brp	Capitalized Contract Cost Capitalized Amount CapitalizedContractCostCapitalizedAmount	3630000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1597000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	927000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23444000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	14039000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	34437000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44903000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26033000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30981000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14527000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14043000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11029000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13101000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	8509000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8509000	usd
CY2023Q1	brp	Deferred Consideration Payments DeferredConsiderationPayments	5412000	usd
CY2022Q4	brp	Deferred Consideration Payments DeferredConsiderationPayments	6840000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8694000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7366000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	108641000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	125743000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	18700000	usd
CY2023Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	100000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	100000	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1500000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1500000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3595303	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	28.26
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	491466	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.10
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	488011	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	28.12
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	44855	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	25.97
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3553903	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	28.14
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13300000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7600000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14132000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	22869000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58712000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55720000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14132000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	22869000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58712000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55720000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2996000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58712000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58716000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	24800000	usd
CY2023Q1	brp	Business Combination And Assets Acquisitions Contingent Consideration Arrangements Liabilities Rangeof Outcomes Value High BusinessCombinationAndAssetsAcquisitionsContingentConsiderationArrangementsLiabilitiesRangeofOutcomesValueHigh	944200000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	18700000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	19700000	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	4700000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	330446000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-25854000	usd
CY2022Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	242848000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	44839000	usd
CY2023Q1	us-gaap	Assets Assets	3448273000	usd
CY2022Q4	us-gaap	Assets Assets	3462182000	usd

Files In Submission

Name	View Source	Status
0001781755-23-000014-index-headers.html	Edgar Link	pending
0001781755-23-000014-index.html	Edgar Link	pending
0001781755-23-000014.txt	Edgar Link	pending
0001781755-23-000014-xbrl.zip	Edgar Link	pending
brp-20230331.htm	Edgar Link	pending
brp-20230331.xsd	Edgar Link	pending
brp-20230331_g1.jpg	Edgar Link	pending
exhibit-101fy2023q1.htm	Edgar Link	pending
exhibit-311fy2023q1.htm	Edgar Link	pending
exhibit-312fy2023q1.htm	Edgar Link	pending
exhibit-32fy2023q1.htm	Edgar Link	pending
exhibit-34fy2023q1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
brp-20230331_cal.xml	Edgar Link	unprocessable
brp-20230331_def.xml	Edgar Link	unprocessable
brp-20230331_lab.xml	Edgar Link	unprocessable
brp-20230331_pre.xml	Edgar Link	unprocessable
brp-20230331_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BWIN
Baldwin Insurance Group, Inc. Stock $bwin

2023 Q1 Form 10-Q Financial Statement

#000178175523000014 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BWIN Baldwin Insurance Group, Inc. Stock $bwin

2023 Q1 Form 10-Q Financial Statement

#000178175523000014 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BWIN
Baldwin Insurance Group, Inc. Stock $bwin